IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,940,741 | +9.4% | 86,877 | -1.1% | 0.03% | +15.4% |
| Q2 2023 | $3,603,132 | +25.1% | 87,817 | +8.9% | 0.03% | +13.0% |
| Q1 2023 | $2,881,252 | -5.4% | 80,617 | 0.0% | 0.02% | -8.0% |
| Q4 2022 | $3,045,000 | -18.9% | 80,617 | -5.0% | 0.02% | -24.2% |
| Q3 2022 | $3,753,000 | +21.7% | 84,863 | +1.9% | 0.03% | +32.0% |
| Q2 2022 | $3,084,000 | -0.7% | 83,318 | -0.6% | 0.02% | +19.0% |
| Q1 2022 | $3,106,000 | +11.4% | 83,863 | -8.5% | 0.02% | +16.7% |
| Q4 2021 | $2,789,000 | -32.0% | 91,663 | -25.1% | 0.02% | -37.9% |
| Q3 2021 | $4,100,000 | -12.1% | 122,303 | +4.6% | 0.03% | -19.4% |
| Q2 2021 | $4,663,000 | -16.9% | 116,963 | -6.2% | 0.04% | -32.1% |
| Q1 2021 | $5,608,000 | -18.8% | 124,738 | +2.1% | 0.05% | -22.1% |
| Q4 2020 | $6,906,000 | +18.8% | 122,138 | -0.3% | 0.07% | +4.6% |
| Q3 2020 | $5,814,000 | -22.1% | 122,538 | -3.2% | 0.06% | -28.6% |
| Q2 2020 | $7,463,000 | +15.4% | 126,576 | -7.5% | 0.09% | -2.2% |
| Q1 2020 | $6,469,000 | -50.4% | 136,826 | -36.6% | 0.09% | -33.1% |
| Q4 2019 | $13,043,000 | +38.8% | 215,912 | +47.7% | 0.14% | +24.1% |
| Q3 2019 | $9,394,000 | 0.0% | 146,166 | 0.0% | 0.11% | 0.0% |
| Q2 2019 | $9,394,000 | -33.8% | 146,166 | -16.4% | 0.11% | -36.7% |
| Q1 2019 | $14,189,000 | +16.2% | 174,802 | -22.6% | 0.18% | +5.4% |
| Q4 2018 | $12,216,000 | +10.2% | 225,967 | +5.1% | 0.17% | +30.2% |
| Q3 2018 | $11,088,000 | +47.1% | 214,959 | +18.8% | 0.13% | +38.7% |
| Q2 2018 | $7,540,000 | -99.8% | 180,937 | +83.3% | 0.09% | +72.2% |
| Q1 2018 | $4,350,255,000 | +39.2% | 98,690 | +58.8% | 0.05% | +42.1% |
| Q4 2017 | $3,125,894,000 | +87.4% | 62,145 | +88.9% | 0.04% | +81.0% |
| Q3 2017 | $1,668,030,000 | -63.8% | 32,900 | -63.7% | 0.02% | -65.6% |
| Q2 2017 | $4,604,651,000 | +263.3% | 90,518 | +241.6% | 0.06% | +238.9% |
| Q1 2017 | $1,267,495,000 | +99311.4% | 26,500 | -0.6% | 0.02% | 0.0% |
| Q4 2016 | $1,275,000 | -99.9% | 26,660 | -5.3% | 0.02% | +20.0% |
| Q3 2016 | $1,031,782,000 | +54.0% | 28,160 | -2.1% | 0.02% | +50.0% |
| Q2 2016 | $669,820,000 | -42.1% | 28,760 | +0.7% | 0.01% | -44.4% |
| Q1 2016 | $1,156,680,000 | -33.5% | 28,560 | +1.7% | 0.02% | -35.7% |
| Q4 2015 | $1,738,809,000 | – | 28,077 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |